RIO DE JANEIRO, Dec. 9 / Amilpar (Bovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3.SA), the largest managed care organization in Brazil, in addition to the Relevant Facts released on November 19, 2009 and December 2, 2009, informs its shareholders and the market that the initiatives to proceed with the Public Offer defined below were started today, having as Applicant its subsidiary AMIL ASSISTENCIA MEDICA INTERNACIONAL LTDA. The filing to register the public offer for the acquisition of shares issued by Medial Saude S.A. ("Medial") due to the control change, at the price of R$ 17.2066 per share, along with the exit from Novo Mercado and delisting of the company was done at CVM - Comissao de Valores Mobiliarios (Brazilian Securities and Exchange Commission), according to article 254-A of Law 6,404/76, CVM Instruction 361/02, BM&FBovespa's Novo Mercado Regulation and the Bylaws of Medial Saude S.A. ("Public Offer").
Amilpar informs that Medial's economic value per share is subject to confirmation through the valuation report to be prepared according to BM&FBovespa's Novo Mercado rules.
Amilpar will keep the market and its shareholders informed about the conclusion of the above-mentioned offer.
To access the Relevant Fact, visit our website at www.amilpar.com.br/ir
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment